Induction and inhibition of Friend erythroleukemia cell differentiation by pyrimidine analogs: analysis of the requirement for intracellular accumulation and incorporation into DNA.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 369890)

Published in Mol Cell Biol on August 01, 1982

Authors

J A Bilello, K K Gauri, J Kühne, G Warnecke, G Koch

Articles cited by this

Erythroleukemic differentiation. Annu Rev Biochem (1978) 5.19

Inhibition of myoblast fusion after one round of DNA synthesis in 5-bromodeoxyuridine. J Cell Biol (1970) 2.84

Toward molecular mechanisms of developmental processes. Annu Rev Biochem (1973) 2.66

Suppression of malignancy and differentiation in melanotic melanoma cells. Proc Natl Acad Sci U S A (1970) 2.44

Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle. Proc Natl Acad Sci U S A (1975) 2.12

5-bromodeoxyuridine-induced differentiation of a neuroblastoma. Proc Natl Acad Sci U S A (1970) 1.86

Induction of erythroid differentiation in vitro by purines and purine analogues. Cell (1976) 1.76

Effects of 5-bromo-2' -deoxyuridine on production of globin messenger RNA in dimethyl sulfoxide-stimulated Friend leukemia cells. Proc Natl Acad Sci U S A (1973) 1.73

Effect of 5-bromodeoxyuridine on expression of cultured chondrocytes grown in vitro. Proc Natl Acad Sci U S A (1969) 1.59

Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell cultures. J Mol Biol (1971) 1.46

On the mechanism of 5-bromodeoxyuridine inhibition of exocrine pancreas differentiation. J Biol Chem (1974) 1.38

Action of 5-bromodeoxyuridine on the induction of haemoglobin synthesis in mouse leukaemia cells resistant to 5-BUdR. Nat New Biol (1973) 1.31

Induction of murine erythroleukemia differentiation by actinomycin D. Proc Natl Acad Sci U S A (1978) 1.15

Early transport changes during erythroid differentiation of Friend leukemic cells. J Cell Physiol (1978) 1.09

The pool size of deoxyguanosine 5'-triphosphate and deoxycytidine 5'-triphosphate in phytohemagglutinin-stimulated and non-stimulated human lymphocytes. Exp Cell Res (1975) 1.01

Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the amount of 5-BrdUrd in DNA. Cell (1977) 0.96

Effect of interferon on dimethyl sulfoxide-stimulated Friend erythroleukemic cells: ultrastructural and biochemical study. J Virol (1977) 0.96

Estrogen receptor has enhanced affinity for bromodeoxyuridine-substituted DNA. Proc Natl Acad Sci U S A (1978) 0.94

Inhibition of myogenesis in a rat myoblast line by 5-bromodeoxyuridine. Nature (1975) 0.87

Amplification of translational control by membrane-mediated events: a pleiotropic effect on cellular and viral gene expression. Ann N Y Acad Sci (1980) 0.83

Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine. Cancer Res (1977) 0.82

Failure of 5-ethyl-2'-deoxyuridine to induce oncogenic RNA (oncorna) viruses in Fischer rat embryo cells and in Balb/3T3 mouse cells. Biochem Pharmacol (1976) 0.82

[Synthesis and photochemical properties of 1'-(2'-deoxy-beta-D-ribofuranosyl)-(4-3H)-5-ethyluracil]. Z Naturforsch B (1969) 0.79

Early decrease of 2-deoxy glucose and alpha-amino isobutyric acid transport are among the first events in differentiating synchronized murine erythroleukemia cells. J Cell Physiol (1979) 0.78

Effect of base analogs upon the induction of differentation in Friend erythroleukemia cells. Adv Ophthalmol (1979) 0.78

Loss of a termolabile thymidine kinase activity in bromodioxyuridine resistant (transport deficient, kinase postive) haploid cultured frog cells. Exp Cell Res (1976) 0.78

Virogenic BrdU and BrdU-sensitive DNA sequences are disproportionately concentrated in the template-active chromatin of rat embryo cells. Nucleic Acids Res (1979) 0.77

Articles by these authors

Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol (1999) 3.74

Selective and reversible inhibition of initiation of protein synthesis in mammalian cells. J Mol Biol (1974) 3.41

BCG vaccination of children against leprosy. Preliminary findings of the WHO-controlled trial in Burma. Bull World Health Organ (1970) 3.39

Synchronization of HeLa cell cultures by inhibition of DNA polymerase alpha with aphidicolin. Nucleic Acids Res (1980) 3.34

Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol (1995) 3.33

Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol (1994) 3.20

Selective blockage of initiation of host protein synthesis in RNA-virus-infected cells. Proc Natl Acad Sci U S A (1975) 2.72

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol (1995) 2.15

Identification of false positive exercise tests with use of electrocardiographic criteria: a possible role for atrial repolarization waves. J Am Coll Cardiol (1991) 2.12

Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol (1991) 2.12

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. J Clin Epidemiol (2010) 2.08

Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site. J Gen Virol (1985) 2.08

A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS (1996) 2.03

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03

Secondary sexual characteristics in boys: estimates from the national health and nutrition examination survey III, 1988-1994. Arch Pediatr Adolesc Med (2001) 2.02

Purification and characterization of poliovirus-induced infectious double-stranded ribonucleic acid. J Biol Chem (1967) 2.00

Codominant analysis of banding data from a dominant marker system by normal mixtures. Genetics (2000) 1.92

A single chicken anemia virus protein induces apoptosis. J Virol (1994) 1.91

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables. J Infect Dis (1998) 1.89

Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87

Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci U S A (2005) 1.86

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85

Unravelling transmission trees of infectious diseases by combining genetic and epidemiological data. Proc Biol Sci (2011) 1.83

Overestimation of numerical distances in the left side of space. Neurology (2004) 1.81

The effect of pethidine on the postnatal adjustment of respiration and acid base balance. Acta Obstet Gynecol Scand (1968) 1.78

An agar cell-suspension plaque assay for isolated viral RNA. Biochem Biophys Res Commun (1966) 1.70

Map-based cloning of chloronerva, a gene involved in iron uptake of higher plants encoding nicotianamine synthase. Proc Natl Acad Sci U S A (1999) 1.70

Poliovirus replicative intermediate: structural basis of infectivity. J Mol Biol (1969) 1.68

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66

Infectious replicative intermediate of poliovirus: purification and characterization. Virology (1969) 1.57

Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56

Review: behaviour management techniques in paediatric dentistry. Eur Arch Paediatr Dent (2010) 1.55

Measuring the diffusion of innovative health promotion programs. Am J Health Promot (1993) 1.54

Psychophysical responses to a speech stressor: correlation of plasma beta-endorphin levels at rest and after psychological stress with thermally measured pain threshold in patients with coronary artery disease. J Am Coll Cardiol (1995) 1.49

Antigenicity of the peplomer protein of infectious bronchitis virus. Mol Immunol (1989) 1.49

Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49

Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44

Hybrid stochastic and deterministic simulations of calcium blips. Biophys J (2007) 1.40

Isolation, characterization and cDNA cloning of nicotianamine synthase from barley. A key enzyme for iron homeostasis in plants. Eur J Biochem (1999) 1.39

Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable. J Infect Dis (2001) 1.38

Guiding outbreak management by the use of influenza A(H7Nx) virus sequence analysis. Euro Surveill (2013) 1.38

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis (2004) 1.38

The mechanism of thymus-dependent antibody formation in bone marrow. J Immunol (1981) 1.37

Judgement criteria for molar incisor hypomineralisation (MIH) in epidemiologic studies: a summary of the European meeting on MIH held in Athens, 2003. Eur J Paediatr Dent (2003) 1.37

Interaction of poliovirus-specific RNAs with HeLa cells and E. coli. Curr Top Microbiol Immunol (1973) 1.34

Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block. J Virol (1975) 1.33

Clostridium botulinum C3 ADP-ribosyltransferase. Curr Top Microbiol Immunol (1992) 1.33

Inhibition of initiation of protein synthesis in mammalian tissue culture cells by L-1-tosylamido-2-phenylethyl chloromethyl ketone. J Biol Chem (1975) 1.33

Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology (1990) 1.31

Nucleoside analog 1592U89 and human immunodeficiency virus protease inhibitor 141W94 are synergistic in vitro. Antimicrob Agents Chemother (1998) 1.31

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry (2011) 1.27

An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum (2003) 1.25

Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J (1977) 1.25

The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol (2010) 1.24

Chicken anaemia virus infection: molecular basis of pathogenicity. Avian Pathol (1995) 1.24

Viral protein synthesis in Friend erythroleukemia cell lines. J Virol (1977) 1.23

The highly pathogenic avian influenza A (H7N7) virus epidemic in The Netherlands in 2003--lessons learned from the first five outbreaks. Avian Dis (2004) 1.23

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol (1999) 1.23

Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus. Avian Pathol (1992) 1.21

Comparison of the transmission characteristics of low and high pathogenicity avian influenza A virus (H5N2). Epidemiol Infect (2003) 1.21

Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother (1993) 1.21

Reversible inhibition of protein synthesis in HeLa cells by dimethylsulfoxide. J Biol Chem (1973) 1.20

Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis (1985) 1.20

Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. Br J Clin Pharmacol (1976) 1.20

Detection in HeLa cell extracts of a 7-methyl guanosine specific enzyme activity that cleaves m7GpppNm. Cell (1975) 1.19

Monoclonal antibodies as probes for defining cellular subsets in the bone marrow, thymus, bursa of fabricius, and spleen of the chicken. Vet Immunol Immunopathol (1988) 1.17

Differentiation of virulent and non-virulent strains of Newcastle disease virus within 24 hours by polymerase chain reaction. Avian Pathol (1997) 1.17

Characterization of a progressive neurodegenerative disease induced by a temperature-sensitive Moloney murine leukemia virus infection. J Virol (1986) 1.17

Identification of sensitive and specific avian influenza polymerase chain reaction methods through blind ring trials organized in the European Union. Avian Dis (2007) 1.17

Murine sarcoma virus gene expression: transformants which express viral envelope glycoprotein in the absence of the major internal protein and infectious particles. Proc Natl Acad Sci U S A (1974) 1.16

Pharmacodynamics of abacavir in an in vitro hollow-fiber model system. Antimicrob Agents Chemother (2002) 1.16

Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol (1994) 1.16

Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15

Propranolol therapy alters estimation of potential cardiovascular risk derived from submaximal postinfarction exercise testing. Am Heart J (1991) 1.14

Adjustment of arterial blood gases and acid base balance in the normal newborn infant during the first week of life. Biol Neonat (1968) 1.13

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine (2001) 1.13

Age estimation up to 16 years of age based on dental development. Odontol Revy (1974) 1.11

Hereditary amelogenesis imperfecta. I. Epidemiology and clinical classification in a Swedish child population. Swed Dent J (1985) 1.10

Simultaneous expression of recombinant baculovirus-encoded chicken anaemia virus (CAV) proteins VP1 and VP2 is required for formation of the CAV-specific neutralizing epitope. J Gen Virol (1998) 1.10

Mechanism of action of gliotoxin: elimination of activity by sulfhydryl compounds. Antimicrob Agents Chemother (1972) 1.08

Competence of suspended HeLa cells for infection by inactivated poliovirus particles and by isolated viral RNA. Virology (1972) 1.08

Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients. Eur J Neurol (2012) 1.08

Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir. Antimicrob Agents Chemother (2000) 1.07

Pooling 12 nomifensine studies for efficacy generalizability. J Clin Psychiatry (1984) 1.07

The effect of early intervention on skeletal pattern in Class II malocclusion: a randomized clinical trial. Am J Orthod Dentofacial Orthop (1997) 1.06

Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins. Br J Cancer (1979) 1.06

Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation. Antimicrob Agents Chemother (1996) 1.06

Concept of "awake venovenous extracorporeal membrane oxygenation" in pediatric patients awaiting lung transplantation. Pediatr Transplant (2012) 1.05

Analysis of the expression of spleen focus-forming virus (SFFV)-related RNA and gp55, a Friend and Rauscher virus-specific protein. Virology (1980) 1.04

The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens. Vet Microbiol (2010) 1.04

The effect of polycations on the interaction of viral RNA with mammalian cells: studies on the infectivity of single- and double-stranded poliovirus RNA. Virology (1968) 1.04

Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology (2001) 1.04

Comparing introduction to Europe of highly pathogenic avian influenza viruses A(H5N8) in 2014 and A(H5N1) in 2005. Euro Surveill (2014) 1.03

Lymphocyte transformation abnormalities in bovine immunodeficiency-like virus infected calves. Immunol Lett (1991) 1.03

Oral hygiene and parent-related factors during early childhood in relation to approximal caries at 15 years of age. Caries Res (2007) 1.03